Back to Search
Start Over
Terran Biosciences Receives FDA Clearance for NM-101, the industry's first software for the analysis of neuromelanin-sensitive MRI
- Source :
- Business Wire. December 20, 2023
- Publication Year :
- 2023
-
Abstract
- MIAMI -- Terran Biosciences, Inc. ('Terran'), a biotech platform company developing therapeutics and technologies for patients with neuropsychiatric illnesses, has received FDA clearance to market NM-101, a cloud-based software platform [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Business Wire
- Publication Type :
- News
- Accession number :
- edsgcl.776814974